No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ABBV241213C145000
- 0.00
- 0.000.00%
15min DelayClose Dec 12 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest145.00Strike Price0.00Turnover0.00%IV-16.28%PremiumDec 13, 2024Expiry Date28.19Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.14Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Unlearn's 2024 Achievements Drive Innovation in AI for Clinical Development
Express News | Hungary's Richter CEO Says Previous Pace of Growth in Dividend Payouts Cannot Be Maintained
Express News | Hungary's Richter CEO Says Company Eyeing Acquisition Targets for Next Year
Express News | Hungary's Richter CEO Expects Slowdown in Sales Growth for Vraylar in 2025
Why AbbVie Inc. (ABBV) Is the Best Safe Stock to Buy According to Analysts?
Press Release: AbbVie Completes Acquisition of Aliada Therapeutics